ZACKS RESEARCH

FUNDS

PORTFOLIO

BROKER RESEARCH

MARKETS

SCREENING

EDUCATION

SERVICES

Earnings

EPS Surprises

Mutual Funds

Options

My Account

Help

Zacks #1 Rank
See how a purely mathematical analysis of earnings estimate revisions returns over 27% per year on average. Click Here to Learn More.

Quote:

Search for Ticker

Free Membership

Search:

GXDX: Genoptix Inc - Full Company Report Enter Ticker:

Quote	Estimates	Charts	Company Reports	News	Financials

Full Company Report \| Estimates \| Brokerage Recommendations \| Comparison to Industry \| Insiders \| Brokerage Reports \| Zacks Equity Research \| Annual Report

GENOPTIX INC (NASD)
GXDX	37.21	0.75	(2.06%)	Vol. 125,869	14:50 ET

Genoptix is a specialized laboratory service provider focused on delivering personalized and comprehensive diagnostic services to community- based hematologists and oncologists. Genoptix is headquartered in Carlsbad, California.

General Information

GENOPTIX INC

2110 Rutherford Road Carlsbad, CA 92008 Phone: 760 268-6200 Fax: 760 268-6201 Web: www.genoptix.com Email: investorrelations@genoptix.com

Industry	MED-OUTP/HM CRE
Sector:	Medical

Fiscal Year End	December
Last Reported Quarter	09/30/09
Next EPS Date	02/25/2010

Price and Volume Information

Zacks Rank
Yesterday's Close	36.46
52 Week High	37.45
52 Week Low	24.15
Beta	0.05
20 Day Moving Average	186,772.59
Target Price Consensus	41.86

% Price Change
4 Week	1.08
12 Week	25.25
YTD	6.98

% Price Change Relative to S&P 500
4 Week	-0.01
12 Week	18.08
YTD	-11.46

Share Information
Shares Outstanding (millions)	17.04
Market Capitalization (millions)	621.35
Short Ratio	15.33
Last Split Date	N/A

Dividend Information
Dividend Yield	0.00%
Annual Dividend	$0.00
Payout Ratio	0.00
Change in Payout Ratio	0.00
Last Dividend Payout / Amount	NA / $0.00

EPS Information
Current Quarter EPS Consensus Estimate	0.34
Current Year EPS Consensus Estimate	1.62
Estimated Long-Term EPS Growth Rate	25.80
Next EPS Report Date	02/25/2010

Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell)	1.67
30 Days Ago	1.67
60 Days Ago	1.67
90 Days Ago	1.80

Fundamental Ratios

P/E
Current FY Estimate:	22.48
Trailing 12 Months:	22.79
PEG Ratio	0.87

EPS Growth
vs. Previous Year	1.92%
vs. Previous Quarter	20.45%

Sales Growth
vs. Previous Year	58.34%
vs. Previous Quarter:	12.16%

Price Ratios
Price/Book	3.70
Price/Cash Flow	18.72
Price / Sales	3.67

ROE
09/30/09	19.20
06/30/09	20.71
03/31/09	20.95

ROA
09/30/09	17.27
06/30/09	18.58
03/31/09	18.79

Current Ratio
09/30/09	9.09
06/30/09	10.37
03/31/09	9.46

Quick Ratio
09/30/09	9.09
06/30/09	10.37
03/31/09	9.46

Operating Margin
09/30/09	16.86
06/30/09	18.86
03/31/09	19.67

Net Margin
09/30/09	29.92
06/30/09	28.68
03/31/09	26.45

Pre-Tax Margin
09/30/09	29.92
06/30/09	28.68
03/31/09	26.45

Book Value
09/30/09	9.84
06/30/09	9.10
03/31/09	8.43

Inventory Turnover
09/30/09	-
06/30/09	-
03/31/09	-

Debt-to-Equity
09/30/09	0.00
06/30/09	0.00
03/31/09	0.00

Debt to Capital
09/30/09	0.00
06/30/09	0.00
03/31/09	0.00


About Zacks \| Advertise \| Media \| Careers \| Contact Us \| Help Disclaimer \| Privacy Policy \| Sitemap NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed. Copyright 2009 Zacks Investment Research